22nd International Vascular Biology Meeting
22nd International Vascular Biology Meeting
批准号:
10391915
负责人:
Rong Wang
金额:
$6.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-01-20 至 2022-12-31
关键词:
AcademiaAgingAmericanAreaAtherosclerosisAwarenessBasic ScienceBiologyBiomedical EngineeringBlood VesselsBrainCOVID-19CellsCellular biologyCitiesClinical MedicineCollaborationsCommunitiesData ScientistDevelopmentDiabetes MellitusDisciplineDiseaseEngineeringEnsureEventEyeFacultyFertilizationFosteringFutureGeneticGeographyGoalsGrowthHealthHeartHematological DiseaseHumanHypertensionImageImmune System DiseasesImmunologicsIndustryInternationalInvestigationKidneyKnowledgeLeadLeadershipLeukocyte TraffickingLiverLungMalignant NeoplasmsMathematicsMedicineNatural ImmunityNatural regenerationNorth AmericaOralParticipantPathologyPermeabilityPhysicsPhysiologicalPostdoctoral FellowPrevention strategyProcessResearchResearch PersonnelRoleScientistSeasonsSecureSiteSymptomsSystems BiologyTherapeuticTimeTranslational ResearchTranslationsUnderrepresented PopulationsVasomotorVirusWomanacquired immunitybaseblood formationbody systemcareerdevelopmental diseasediversity and equitydrug discoverygraduate studentimprovedinnovationinsightmeetingsmembernervous system disordernew technologynext generationnovelnovel diagnosticsnovel therapeuticspostersprogramsracial and ethnicracial diversityregenerativesight restorationskillsstem cell differentiationsymposiumtreatment strategytumor growthvascular bedvascular factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Since its inception in 1980, the International Vascular Biology Meeting (IVBM) has been a time-honored and
profoundly impactful biennial event. This meeting provides a unique opportunity for the global community to
exchange and discuss new scientific discoveries, and to chart innovative and collaborative future scientific
directions in vascular biology. The IVBM has also served to foster the next generation of scientists in vascular
medicine. IVBM 2022 (October 13-17, 2022 in Oakland, CA) will cover a broad spectrum of vascular biology,
prioritizing emerging areas of research. The vasculature impacts every organ system in development, aging, and
disease and is critical to processes of regeneration. Blood vessel walls regulate multiple physiological functions,
including vasomotor tone, leukocyte trafficking, innate and acquired immunity, permeability, stem cell
differentiation, regeneration, and new blood formation. Abnormalities in any of these functions lead to disease.
Beyond traditional vessel wall pathologies such as atherosclerosis and hypertension, the vasculature contributes
to cancer, neurological disease, diabetes, hematological and immunological disorders, aging, and infectious
processes, most recently COVID-19. Mounting evidence suggests that many COVID-19 symptoms are due to
the virus attacking the vasculature. Advances in vascular biology have led to the development of many new
therapies and preventive strategies with broad impact including those mitigating tumor growth and restoring
vision. IVBM 2022 will provide a timely forum to exchange new knowledge in the rapidly expanding field of
vascular biology, facilitate cross-disciplinary collaboration and critical interactions between seasoned
investigators and trainees, and promote awareness of diverse vascular beds in health and disease. Our objective
is to ignite novel areas of research between academia and industry, and from basic to translational research and
clinical medicine, with the ultimate goal of improving human health. IVBM 2022 is being organized by the North
American Vascular Biology Organization (NAVBO), an organization with a strong track record of promoting
trainees and junior faculty. A significant number of oral presentations are reserved for junior scientists to promote
their career growth. NAVBO is committed to diversity and equity within and beyond the vascular biology
community; the IVBM organizers and speakers include women, junior faculty, underrepresented groups, and
scientists from around the world. We selected the diverse city of Oakland, CA as the conference site. Our
program facilitates cross-fertilization of scientific insights related to different vascular beds (brain, heart, lung,
kidney, liver, and eye) and diverse disciplines (cell biology, genetics, imaging, bioengineering, mathematics,
physics, systems biology, translational research, and drug discovery). By promoting such interactions, we will
generate new basic knowledge of developmental and disease processes, catalyze innovation, and expedite
development of new diagnostic, regenerative and other therapeutic approaches. By engaging young
investigators and fostering diversity we will enrich the field of vascular biology and secure its future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Pathogenesis of Hereditary Hemorrhagic Telangiectasia
-
批准号:10083767
-
项目类别:
-
资助金额:$43.62万
-
财政年份:2020
-
负责人:Rong Wang
-
依托单位:
Molecular Pathogenesis of Hereditary Hemorrhagic Telangiectasia
-
批准号:10339385
-
项目类别:
-
资助金额:$47.55万
-
财政年份:2020
-
负责人:Rong Wang
-
依托单位:
Molecular Pathogenesis of Hereditary Hemorrhagic Telangiectasia
-
批准号:9917601
-
项目类别:
-
资助金额:$43.52万
-
财政年份:2020
-
负责人:Rong Wang
-
依托单位:
Molecular Pathogenesis of Hereditary Hemorrhagic Telangiectasia
-
批准号:10614453
-
项目类别:
-
资助金额:$47.55万
-
财政年份:2020
-
负责人:Rong Wang
-
依托单位:
Comparative Effectiveness of Treatments for Acute Myeloid Leukemia in the Elderly
-
批准号:8693973
-
项目类别:
-
资助金额:$8.08万
-
财政年份:2013
-
负责人:Rong Wang
-
依托单位:
Comparative Effectiveness of Treatments for Acute Myeloid Leukemia in the Elderly
-
批准号:8583443
-
项目类别:
-
资助金额:$8.33万
-
财政年份:2013
-
负责人:Rong Wang
-
依托单位:
Molecular pathogenesis and treatment of brain arteriovenous malformation
-
批准号:8117203
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2010
-
负责人:Rong Wang
-
依托单位:
Molecular Pathogenesis of Brain Arteriovenous Malformation
-
批准号:9242700
-
项目类别:
-
资助金额:$34.7万
-
财政年份:2010
-
负责人:Rong Wang
-
依托单位:
Molecular pathogenesis and treatment of brain arteriovenous malformation
-
批准号:7987203
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2010
-
负责人:Rong Wang
-
依托单位:
Molecular pathogenesis and treatment of brain arteriovenous malformation
-
批准号:8269939
-
项目类别:
-
资助金额:$29.38万
-
财政年份:2010
-
负责人:Rong Wang
-
依托单位:
Molecular Pathogenesis of Brain Arteriovenous Malformation
-
批准号:9065648
-
项目类别:
-
资助金额:$35.06万
-
财政年份:2010
-
负责人:Rong Wang
-
依托单位:
Molecular pathogenesis of brain arteriovenous malformation
-
批准号:8739990
-
项目类别:
-
资助金额:$40.37万
-
财政年份:2009
-
负责人:Rong Wang
-
依托单位:
Development of new elastic titanium immediate load implants
-
批准号:7322827
-
项目类别:
-
资助金额:$9.84万
-
财政年份:2007
-
负责人:Rong Wang
-
依托单位:
PROTEOMEX LTQ WORKSTATION SHARED INSTRUMENTATION: PROTEOMICS
-
批准号:7335154
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2006
-
负责人:Rong Wang
-
依托单位:
PROTEOMEX LTQ WORKSTATION SHARED INSTRUMENTATION: INFLUENZA
-
批准号:7335153
-
项目类别:
-
资助金额:$2.97万
-
财政年份:2006
-
负责人:Rong Wang
-
依托单位:
PROTEOMEX LTQ WORKSTATION SHARED INSTRUMENTATION: AIDS
-
批准号:7335150
-
项目类别:
-
资助金额:$4.66万
-
财政年份:2006
-
负责人:Rong Wang
-
依托单位:
PROTEOMEX LTQ WORKSTATION SHARED INSTRUMENTATION: DIABETES,AUTOIMMUN THYROID DIS
-
批准号:7335152
-
项目类别:
-
资助金额:$2.97万
-
财政年份:2006
-
负责人:Rong Wang
-
依托单位:
PROTEOMEX LTQ WORKSTATION SHARED INSTRUMENTATION: CANCER, LEUKEMIA
-
批准号:7335151
-
项目类别:
-
资助金额:$10.18万
-
财政年份:2006
-
负责人:Rong Wang
-
依托单位:
ID OF MINIBRAIN KINASE/DUAL-SPECIFICITY YAK 1-RELATED KINASE 1A P-SITES IN DYN-
-
批准号:7355062
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2006
-
负责人:Rong Wang
-
依托单位:
Notch Signaling in Mouse Arterial-Venous Specification
-
批准号:6926583
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2005
-
负责人:Rong Wang
-
依托单位:
海外基金